Background-Frequency-domain optical coherence tomography (FD-OCT) is easily able to define both pre-and post-stenting features of the atherosclerotic plaque that can potentially be related to periprocedural complications. We sought to examine which FD-OCT-defined characteristics, assessed both before and after stent deployment, predicted periprocedural (type IVa) myocardial infarction (MI). Methods and Results-FD-OCT was performed before and after coronary stenting in 50 patients undergoing percutaneous coronary intervention (PCI) for either non-ST segment elevation MI (NSTEMI) or stable angina. All patients underwent single-vessel stenting, and only drug-eluting stents were implanted. Troponin T was analyzed on admission, before PCI, and at 12 and 24 hours after PCI, and type IVa MI was defined in stable angina as a rise of at least 3ϫ upper reference limit and in NSTEMI as a pre-PCI troponin T fall, followed by post-PCI troponin T rise Ͼ20%. 
P eriprocedural myocardial infarction (type IVa
is caused by procedure-related cell necrosis that occurs after percutaneous coronary intervention (PCI). It is diagnosed when an increase of a marker of cardiac necrosis is observed and remains a frequent complication of PCI, occurring in between 5% and 44% of the procedures. 2, 3 Of note, even a small post-PCI biomarker increase is significantly associated with an adverse short-and long-term outcome. 4 Previous studies have used intravascular ultrasound (IVUS) to identify atheroma features associated with type IVa MI, showing both plaque burden 5, 6 and necrotic core 7, 8 as strong risk factors. Few studies, however, have involved post-PCI evaluation. 5, 9 Two recent studies showed time-domain optical coherence tomography (TD-OCT) defined thin-cap fibroatheroma (TCFA) to be associated with type IVa MI 10, 11 ; these studies, however, were conducted on pre-PCI images only.
We sought to systematically examine frequency-domain (FD)-OCT-defined plaque features, assessed both before and after the procedure, in order to establish their potential impact on type IVa MI, defined as a postprocedural increase of troponin T (TnT) levels. 1 
WHAT IS KNOWN
• Periprocedural (Type IVa) myocardial infarction, which is a frequent complication of percutaneous coronary intervention in stable and unstable patients, has prognostic implications for long-term outcomes.
• Intravascular ultrasound studies suggest that larger plaque volumes with an extensive lipid core in the target lesion are related to an increased risk of periprocedural myocardial infarction.
• Time-domain optical coherence tomography data highlight thin-cap fibrous atheroma as a predictor of periprocedural myocardial infarction.
WHAT THE STUDY ADDS
• Frequency-domain optical coherence tomography, performed both before and after percutaneous coronary intervention, confirms the presence of thin-cap fibrous atheroma and adds intrastent thrombus and intrastent dissection as independent predictors of periprocedural myocardial infarction.
• Tissue prolapse through stent struts not associated with periprocedural myocardial infarction.
Methods

Study Population
Fifty patients presenting with either non-ST elevation MI (NSTEMI) (25 patients) or stable angina (25 patients) were retrospectively extracted from the FD-OCT database of the Department of Cardiovascular Medicine, Policlinico A. Gemelli, Catholic University of the Sacred Heart, Rome, Italy, out of the 151 patients who underwent FD-OCT examination from June 2010 to June 2011. All patients had to undergo PCI with a single-stent implantation for a single, native, de novo coronary lesion. A study flow chart is reported in Figure 1 . Patient-related exclusion criteria were PCI for ST elevation MI (STEMI) or multiple PCI during the index procedure. Other exclusion criteria were fever, malignancy, left ventricular ejection fraction Ͻ45%, atrial fibrillation, and reduced renal function (creatinine clearance Ͻ60 mL/min) because of concerns regarding the specificity of TnT in such patients. 12 All patients received a drug-eluting stent, and none were treated with IIb-IIIa glycoprotein inhibitors. Lesion-related exclusion criteria were left main or aorto-ostial involvement, heavily calcified lesion, tortuous vessel, or angiographic evidence of coronary dissection or side branch occlusion after PCI. NSTEMI was defined as progressive crescendo pattern or angina at rest, associated with ST segment depression or T-wave inversion on EKG and increased admission TnT (at least Ͼ0.03 mg/dL). Stable angina was defined as no change in frequency, duration, or intensity of angina symptoms within 6 weeks before PCI.
Type IVa MI Definition and TnT Assay
Patients were divided into 2 groups, based on TnT-defined type IVa MI. TnT was measured using Roche Diagnostics reagents on an Elecsys 2010 Immunoassay Analyzer. The lower detection limit was 0.01 ng/mL (99th percentile of reference control group). TnT was analyzed at admission, before PCI and at 12 and 24 hours after PCI. Type IVa MI was defined in patients with stable angina (all had undetectable pre-PCI troponin values) as a rise of at least 0.03 mg/dL (Ͼ3 times the 99 th percentile of the upper reference limit) in post-PCI TnT values. 1 Type IVa MI was defined in NSTEMI as a pre-PCI TnT fall pattern, followed by post-PCI TnT rise of Ͼ20% in at least 1 out of 2 post-PCI determinations. 1, 13 All patients were treated with aspirin (100 mg/d), clopidogrel (600-mg loading dose, followed by 75 mg/d), and statins. Patients with NSTEMI were also treated with weight-adjusted low-molecular-weight heparin. The study protocol was approved by the institutional review board, and informed written consent was obtained from each patient.
PCI and FD-OCT Procedures
PCI was performed with a 6Fr guiding catheter in all patients. Unfractionated heparin was administrated during PCI, with a target activated clotting time of Ͼ250 seconds. A 0.014-inch guide wire was placed distally in the target vessel, and an intracoronary injection of 200 g of nitroglycerin was performed. FD-OCT images were acquired with a commercially available system (C7 System; LightLab Imaging Inc/St Jude Medical, Westford, MA) after the OCT catheter (C7 Dragonfly; LightLab Imaging Inc/St Jude Medical, Westford, MA) was advanced to the distal end of the target lesion. The first FD-OCT run was conducted before either direct stent implantation or balloon predilatation (pre-PCI run). The entire length of the region of interest was scanned using the integrated automated pullback device at 20 mm/s. During image acquisition, coronary blood flow was replaced by continuous flushing of contrast media directly from the guiding catheter at a rate of 4 mL/s with a power injector (MEDRAD Avanta®, Siemens, Germany) in order to create a virtually blood-free environment. Twenty-one out of 50 lesions (42%) were predilated with undersized (1.5 or 2 mm) compliant balloons. Stenting was performed using a single drugeluting-stent implantation. Postdilatation with a noncompliant balloon was performed in 33 out of 50 stents (66%). A second FD-OCT run was subsequently performed (post-PCI run). No FD-OCT related complications occurred.
FD-OCT Image Analysis
All images were recorded digitally, stored, and every single frame (0.2 mm) analyzed by 2 independent investigators (I.P. and L.D.V.), who were blinded to clinical and laboratory data. When there was discordance between the observers, a consensus was obtained. Offline analysis was performed with proprietary software (LightLab Imaging) after confirming proper calibration settings of the Z-offset.
FD-OCT plaque analysis was conducted on pre-PCI runs and was restricted to the vessel segment that was stented on the post-PCI run using fiduciary landmarks (bifurcations, calcium). Plaque analysis was targeted to plaque characterization, ruptured plaque, TCFA (Figure 2A) , thrombus, 14, 15 and microvessels. 16 When a plaque contained 2 or more lipid-containing quadrants, it was considered a lipid-rich plaque, and lipid arc and cap thickness were measured. 11 TCFA was defined as a lipid-rich plaque with a fibrous cap thickness of Յ65 m. 15, 17 A microchannel was defined as a no-signal tubuloluminal structure without a connection to the vessel lumen recognized on Ն3 consecutive cross-sectional OCT images. 17 Thrombus was identified as a mass with dorsal shadowing protruding into the vessel lumen or discontinuous from the surface of the vessel wall. 14 FD-OCT stent analysis was also performed on post-PCI runs and was targeted to intrastent thrombus 18 Figure 2E ), incomplete stent apposition, 20 malapposition length, and number of malapposed struts per cross-section 21 ( Figure  2F ). Intrastent thrombus was defined as an irregular mass with dorsal shadowing protruding into the lumen or a luminal mass with dorsal shadowing that was not connected to the vessel wall. 18 Intrastent dissection was defined as a disruption of the luminal vessel surface in the stented segment, while edge dissection was a disruption of the luminal vessel surface at stent edges (within 5 mm proximal and distal to the stent, with no visible struts). 18 Tissue prolapse was defined as a convex-shaped protrusion of tissue between adjacent stent struts toward the lumen, without disruption of the continuity of the luminal vessel surface and with a luminal extension of Ͼ50 m. 18 Maximal intraluminal prolapse length was measured as a perpendicular distance from the arc connecting adjacent struts to the greatest extent of protrusion. 18 Prolapse volume (mm 3 ) was calculated as the sum of tissue prolapse area (mm 2 ) of each cross-section multiplied by the longitudinal prolapse length (mm). Incomplete stent apposition was defined as a clear separation between at least 1 stent strut and the vessel wall. 20 A malapposed stent strut was identified when this distance was higher than the sum of strut thickness plus abluminal polymer thickness, according to the stent manufacturer's specifications plus a compensation factor of 20 m to correct for strut blooming. 22 Distances between the endoluminal surface of the strut reflection and the surface of the vessel wall within stent strut shadow were measured 21 (malapposition length).
Quantitative Coronary Angiographic Analysis
Quantitative coronary angiographic analysis was performed with a validated edge detection system (CAAS Version 5.9, Pie Medical Imaging, Maastricht, the Netherlands). The reference vessel diameter, minimal lumen diameter, and lesion length were measured in pre-and post-PCI diastolic frames from orthogonal projections according to validated protocols. 23 Final angiographic result was assessed by Thrombolysis In Myocardial Infarction flow grade. 24 
Statistical Analysis
Statistical analysis was performed using SPSS 17.0 (SPSS, Inc, Chicago, Illinois). Categorical variables are presented as frequencies and analyzed with the Chi 2 test or Fisher exact test. Most continuous variables were not normally distributed as assessed by the Kolmogorov-Smirnov test for normality, and thus were presented as median and interquartile range (IQR), and natural logarithmic transformation was applied to the data to allow the Student t test to be used. Pearson's r correlation coefficient was calculated between cap thickness and tissue prolapse. Multivariate logistic regression was performed to assess the impact of a set of factors on periprocedural MI (dependent variable). Univariate analysis was first performed, and all the variables that exhibited a PϽ0.05 were entered en bloc in the multivariate model, along with age and sex as background variables. Model fit was assessed using the Hosmer-Lemeshow goodness of fit model. Cox and Snell R 2 and Nagelkerke R 2 were used to identify the amount of variation in the dependent variable explained by the model. Intraobserver and interobserver differences were investigated with measure of agreement. A probability value Ͻ0.05 was considered significant.
Results
Clinical Characteristics and Angiographic Results
Clinical characteristics of the enrolled patients are shown in Table 1 .
Type IVa MI was diagnosed in 21 patients, while the other 29 were the control group. The type IVa MI group had a median12-hour post PCI TnT of 0.72 ng/dL (IQR 0.04 to 0.85) that decreased to a median of 0.38 ng/dL (IQR 0.06 to 0.45) at 24-hour post-PCI determination. No patient had significant electrocardiographic changes after PCI, while transient chest pain was observed in 3 patients in the type IVa MI group. In all cases, chest pain subsided after a maximum of 3 hours.
Fifty vessels were analyzed: 22 were Left Anterior Descending, 16 were Left Circumflex, and 12 were Right Coronary Artery. All lesions were successfully treated with stenting: 29 with everolimus-eluting stent (Xience Prime, Abbott) and 21 with zotarolimus-eluting stent (Resolute Integrity, Medtronic). Quantitative coronary angiographic results are shown in Table 2 . Minimal lumen diameter, reference vessel diameter, and stenosis percentage were not different between groups at both pre-PCI and post-PCI angiograms. Angiographic thrombus and final Thrombolysis In Myocardial Infarction flow 0 to 2 were not different between groups.
Pre-PCI FD-OCT Findings
FD-OCT results for plaque analysis conducted on pre-PCI runs are shown in Table 3 .
TCFA was the only feature significantly associated with type IVa MI (76.2% versus 41.4%; Pϭ0.017). In contrast, minimum lumen area, frequency of lipid plaques, lipid plaque cap thickness, and lipid arc angle were not different between groups, but when the number of lipid quadrants was considered, a trend toward a higher number of lipid quadrants was observed in the type IVa MI group. Finally, presence of thrombus and microvessels did not significantly differ between groups.
Post-PCI FD-OCT Findings
FD-OCT results for stent analysis conducted on post-PCI runs are shown in Table 4 .
Intrastent thrombus was significantly more frequent in type IVa MI than in the control group (61.9% versus 20.7%; Pϭ0.04), as was intrastent dissection (61.9% versus 31%; Pϭ0.03). In contrast, tissue prolapse volume, maximal intraluminal prolapse length, incomplete stent apposition, malapposition length, and the number of malapposed struts per cross-section were not significantly different between groups, as was stent edge dissection. We were not able to find other significant associations between pre-and post-FD-OCT findings, with the exception of the calculated Pearson correlation coefficient between cap thickness pre-PCI and maximal intraluminal prolapse length on post-PCI images (RϭϪ0.53; Pϭ0.04).
Predictors of Type IVa MI
The findings of univariate and multivariate logistic regression using type IVa MI as dependent variable are shown in Table 5 .
The final multivariate model contained 5 variables (age, male sex, TCFA, intrastent thrombus, and intrastent dissection). The 2 value for the Hosmer-Lemeshow test was 6.93, with a significant level of 0.54. The strongest predictor of type IVa MI was TCFA, followed by intrastent dissection and intrastent thrombus. Moreover, the predictors were not related to each other as suggested by 2 analysis of TCFA and intrastent thrombus (Pϭ0.16) or TCFA and intrastent dissection (Pϭ0.69) and intrastent thrombus and intrastent dissection (Pϭ0.70).
Intraobserver and Interobserver Agreement
We tested the degree of agreement for TCFA in pre-PCI runs and for intrastent thrombus in post-PCI runs. Kappa measure of agreement for intraobserver agreement was 0.96 (Pϭ0.0001) for TCFA and 0.92 (Pϭ0.0001) for intrastent thrombus. Interobserver variability for TCFA and intrastent thrombus was 0.84 (Pϭ0.0001) and 0.84 (Pϭ0.0001), respectively.
Discussion
Our study identified FD-OCT-defined TCFA, intrastent thrombus, and intrastent dissection as independent predictors of type IVa MI. In contrast, ruptured plaque and plaque "prolapse" through stent struts were not significantly associated with type IVa MI. Values are expressed as median (interquartile range) or absolute number of cases (relative percentage) as appropriate. Minimal luminal diameter (MLD), reference diameter (RD), percentage (%) stenosis before and after PCI were calculated by quantitative coronary angiography (QCA) analysis. Bifurcated lesions were defined as lesions Ͼ50% located in a major bifurcation and with a main vessel visual diameter Ն2.5 mm and a side branch visual diameter Ն2.0 mm. Thrombus refers to angiographic evidence of haziness into the culprit vessel. TCFA is characterized by a necrotic core and a thin fibrous cap 25 and is often associated with positive vessel remodeling, 26 all features of rupture-prone plaque. 27 While the association between the presence of a necrotic core and type IVa MI had previously been ascertained using radiofrequencybased analysis of IVUS images, 28, 29 recent studies have shown that OCT-defined TCFA, also when considered in its single components, namely reduced cap thickness 10 and greater number of lipid quadrants, 30 is associated with type IVa MI and/or angiographic slow flow, in both stable 11, 27 and unstable patients 30 ; however, the previous version of OCT (time-domain) was used in these studies, and the culprit vessel was not imaged after stenting. We were able to broadly confirm the association of TCFA with type IVa MI, and we also found more lipid quadrants (although this difference was not strictly significant) in type IVa MI group, but we failed to find differences for cap thickness. While this discrepancy may be related to our smaller sample size, we, like Tanaka and colleagues, 30 included patients with NSTEMI, who, on average, have a less thick fibrous cap than stable patients (see online-only Supplemental Table 1 ), 31 thus potentially diluting the effect of a thin cap on type IVa MI. Interestingly, while maximal intraluminal prolapse was higher in patients with an underlying TCFA, it did not predict type IVa MI.
Previous studies from a single Japanese group found an association between prestenting ruptured plaque and type IVa MI assessed by post-PCI creatine kinase-MB (CK-MB). 10, 27 While the morphology of these ruptures differed according to the clinical presentation, 31 a very recent study from the same cohort failed to confirm a significant association between ruptured plaque and type IVa MI assessed by troponin I elevation. 11 In our cohort, also, we could not confirm this association using TnT. The reasons for this discrepancy are not clear and might be related to the different sensitivity of troponins versus CK-MB assays in the detection of myocardial damage, as well as to the different prevalence of ruptured plaque in the 2 studies.
The most novel part of our results lies in the identification of intrastent thrombus and intrastent dissection at post stenting FD-OCT analysis as predictors of type IVa MI, as well as in the lack of association with prestenting thrombus, ruptured plaque, and plaque tissue prolapse.
Recently, Lee and colleagues 11 failed to find an association between prestenting thrombus presence and type IVa MI assessed by increased troponin I. Accordingly, Yonetsu and colleagues 10 could not find any relation between prestenting thrombus presence and type IVa MI, as defined by increased CK-MB. We confirmed these data in a cohort of TnT-defined type IVa MI, but we were additionally able to show that post-PCI intrastent thrombus was a good and independent predictor of type IVa MI. Indeed, pre-PCI thrombus may be crushed beneath the stent struts, thus preventing possible embolization. Post-PCI intrastent thrombus, instead, developing on the luminal side of the stent struts, is theoretically able to embolize distally. 32 This notion is in keeping with the idea that increased platelet reactivity is a major risk factor for type IVa MI. 33 Of note, very recently, a genetic allele linked to limited clopidogrel efficacy has been associated with intrastent thrombus as defined by FD-OCT. 34 Additionally, we found intrastent dissection as a predictor of type IVa MI, while no association was detected with edge dissection. Recently, Gonzalo and colleagues 18 showed different OCT-defined features between these 2 types of dissection. Intrastent dissection is usually composed of multiple, small intimal tears across the imaged cross-section, while it is of limited longitudinal length. On the other hand, edge dissection is usually a long and single intimal break, extending outside the stent, predicted by the presence of an underlying fibrocalcific or lipid-rich plaque. 19 While we can only indirectly infer on the differential association of these 2 types of dissection with type IVa MI, it is likely that multiple intrastent flaps might work as potential foci for microthrombosis and platelet aggregation.
It must be noted that the specific combination of predictors (TCFA, intrastent thrombus, and intrastent dissection) of type IVa MI in this carefully selected sample is likely to underscore an embolic origin of these periprocedural infarctions. Other mechanisms (such as neurohormonal activation, inflammation, or oxidative stress), however, could not be excluded. 35 Also interesting in our study is the lack of association between the presence and amount of plaque prolapse and type IVa MI. Prolapse of plaque material on the luminal side of a stent has been previously studied by IVUS and shown to occur in one fourth of infarct-related arteries 9 and in 16% of stable patients with diabetes. 36 It was predicted by plaque rupture and positive remodeling, together with longer stent length 9 and certain stent types. 37 Plaque prolapse volume by IVUS predicted type IVa MI in a sample of patients with acute coronary syndrome. 9 Of note, these studies were all conducted with 20-MhZ IVUS systems, likely to severely underestimate the amount of tissue prolapse because of its low resolution. Moreover, IVUS is not able to differentiate poststenting prolapse from intrastent thrombus, because of their similar echogenicity. 38 With OCT, in contrast, tissue prolapse is observed almost universally after stenting 18, 20 and can be readily differentiated from thrombus. 17 Finally, the overall incidence of type IVa MI in our sample (21/50, 42%), while relatively high, is in line with previous data. Indeed, a Ͼ3ϫ upper limits of normal troponin elevation was observed in around 25% of stented patients in Lee's paper, 11 only involving stable patients, and in 47% of a sample similar to ours. 39 Moreover, the high overall incidence (33/50, 66%) of postdilatation with noncompliant balloons, which is common practice in our center, may also explain why it did not predict type IVa MI by itself.
Limitations
Two important limitations of our study lay in the fact that we have defined type IVa MI on the basis of raised TnT only, without measuring CK-MB, and that we have analyzed a mixed population including patients with stable angina and NSTEMI.
The "Universal Definition" of MI highlights troponins instead of CK-MB as the best biomarker to define type IVa MI. 1 Troponin absolute elevation after stenting was strongly correlated with magnetic resonance-defined myocardial necrosis for both patients with stable angina and NSTEMI. 35 In our sample, we showed median TnT values to be as high as 72ϫ the 99 th percentile of the upper reference limit at 12 hours post-PCI, and 38ϫ at 24 hours post-PCI. Thus, we can assume that TnT elevations seen in our cohort truly represent the release from myocardial necrotic areas. 36 Moreover, we defined type IVa MI in the NSTEMI group as a fall-and-rise TnT pattern with an increase of Ͼ20%, as suggested by a consensus document 1 and a published study. 13 Another limitation concerns the small size of our sample. While a multicenter registry is mandatory in order to fully evaluate the prognostic role of FD-OCT, our study is a singlecenter study that has used tight inclusion criteria (such as a single, de novo lesion treated with a single, third-generation drug-eluting stent) and strict exclusion criteria 13 ; however, our results have still to be considered as only hypothesis-generating.
Finally, although thrombus tends to have an irregular surface; tissue prolapsed, a smooth border; and dissections, a linear appearance, the final differentiation among these entities remains a potential limitation of OCT.
Conclusions
In conclusion, presence of TCFA at pre-PCI FD-OCT, and of intrastent thrombus and intrastent dissection at post-PCI FD-OCT predict type IVa MI in a contemporary sample of patients treated with second-generation drug-eluting stents. Interestingly, 2 of the 3 predictors of type IVa MI were not apparent at pre-PCI FD-OCT.
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